Records containing: HIV-1-infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-05-23Observational Assessment of the Nation-wide Roll-out of Dolutegravir in Lesotho
-
CLINICAL_TRIALS study record update · 2023-05-10Optimising Cohorts for HIV Cure Interventions: the Role of Very High CD4 T Cell Counts: HI-ART Study
-
CLINICAL_TRIALS study record update · 2023-05-10A Proof of Concept Study to Evaluate the Safety and Efficacy of UB-421 in Combination With Chidamide for Reduction of HIV Reservoir as Compared to UB-421 Alone in ART Stabilized HIV-1 Patients Who Undergo ART Interruption
-
CLINICAL_TRIALS study record update · 2023-04-21A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein ConM SOSIP.v7 gp140 Vaccine, Adjuvanted With MPLA Liposomes, in Healthy, HIV-Uninfected Adults
-
CLINICAL_TRIALS study record update · 2023-04-04A Phase IIA Randomized Double-blind Placebo-controlled Single-centre Study of the Effect of Bacillus Calmette-Guérin (BCG) Vaccination on the HIV Latent Reservoir
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-03-31Identifying and Engaging Urban HIV Infected and Uninfected YBMSM in Care
-
CLINICAL_TRIALS study record update · 2023-03-30VIH-1 Colo-rectal Transmission by Infected Semen Cells and Effects of Seminal Plasma ex Vivo
-
CLINICAL_TRIALS study record update · 2023-03-10A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) in HIV-1 Uninfected Adults in Good General Health
-
CLINICAL_TRIALS study record update · 2023-03-07A Phase 1 Dose-escalation Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Bispecific Antibody 10E8.4/iMab in HIV-1-infected and Uninfected Individuals
-
CLINICAL_TRIALS study record update · 2023-02-21A Phase 1, Double-blind, Placebo-controlled Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2023-02-10Impact of M184V on the Virological Efficacy to Lamivudine/Dolutegravir
-
CLINICAL_TRIALS study record update · 2023-02-10Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2023-02-08The Efficacy and Safety of Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2023-01-09UNCPMZ 41901 - An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women: a Pilot Study
-
CLINICAL_TRIALS study record update · 2023-01-09Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites
-
CLINICAL_TRIALS study record update · 2023-01-05Open-label Switch Study From a Regimen of Elvitegravir/Tenofovir Alafenamide/Emtricitabine/Cobicistat and Darunavir, to a FDC of Bictegravir/Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed HIV-l Subjects Known to Have an 184 V/I Mutation
-
CLINICAL_TRIALS study record update · 2022-12-20A Phase 4, Single-Arm Study of the Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Patients With Active Illicit Substance Use
-
CLINICAL_TRIALS study record update · 2022-12-19A Phase 2 Randomized, Open Label, Active Controlled Study Evaluating the Safety and Efficacy of Long-acting Capsid Inhibitor GS-6207 in Combination With Other Antiretroviral Agents in People Living With HIV
-
CLINICAL_TRIALS study record update · 2022-12-15Effect of Dolutegravir Intensification on Blood and Tissue Latent HIV-1 Reservoirs and on Residual Viremia Despite ART
-
CLINICAL_TRIALS study record update · 2022-12-14Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching From Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate to Bictegravir/ Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Virologically Suppressed Adults
-
CLINICAL_TRIALS study record update · 2022-12-06Fitness and Longevity in Exercise
-
CLINICAL_TRIALS study record update · 2022-12-02Social Media for ART Adherence and Retention in Adolescents and Young Adults: the Vijana-SMART Study
-
CLINICAL_TRIALS study record update · 2022-11-29European HIV&STI Prevention Network Study
-
CLINICAL_TRIALS study record update · 2022-11-07Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women An Open-Label Randomised Control Study
-
CLINICAL_TRIALS study record update · 2022-11-04Phase IV, Single-center, Open Study to Evaluate the Benefits of the Start of Immediate Treatment Without Immunovirological Data ("Same Day Treatment") Compared to Conventional Treatment With BIC / FTC / TAF (Bictegravir/Emtricitabina/Tenofovir) in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection